Kaushal Mohit's Form 4 filing
Starling Oncology, Inc. (DFPH) · filed Nov 15, 2022
- Accession no.
- 0001799191-22-000006
- Filed
- Nov 15, 2022
- Trade date
- Nov 14, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $34.1K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kaushal MohitCIK 0001683021 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 14, 2022 | Common Stock | SSaleDisposed | −15,994 | $2.13F2 | −$34,067.22 | 25,534 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Price is the volume weighted average selling price of all sales by the Reporting Person on November 14, 2022 within a one-dollar range. Actual prices ranged from $2.08 to $2.18. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.